Crossmark

Cost analysis of treatment with therapeutic plasma exchange versus treatment with intravenous immunoglobulins in patients with immune-based neurological diseases. Proposal for optimising the use of plasmatic blood products

Crossref DOI link: https://doi.org/10.1016/j.nrleng.2025.04.003

Published Print: 2025-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Antelo, M. Luisa

Zalba Marcos, S.

Jericó, I.

Sarobe, M.

Torné, L.

Erro, M. Elena

García-Erce, J.A.
License Information

Text and Data Mining valid from 2025-05-01

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-04-06
More Information

This article is maintained by: Elsevier

Article Title: Cost analysis of treatment with therapeutic plasma exchange versus treatment with intravenous immunoglobulins in patients with immune-based neurological diseases. Proposal for optimising the use of plasmatic blood products

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2025.04.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2023.08.002

Content Type: article

Copyright: © 2024 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below